Stoke Therapeutics earnings missed by $0.07, revenue topped estimates
NeutralFinancial Markets

Stoke Therapeutics reported earnings that fell short of expectations by $0.07, but their revenue exceeded estimates, indicating a mixed performance in their latest financial results.
— Curated by the World Pulse Now AI Editorial System







